A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load

Annals of Clinical Biochemistry

Volumn 46, Issue 6, 2009, Pages 457-463

  Ai, Masumi ^a   Tanaka, Akira ^a,b   Shimokado, Kentaro ^a   Ohtani, Rumiko ^c   Inazu, Akihiro ^c   Kobayashi, Junji ^c   Mabuchi, Hiroshi ^c   Nakano, Takamitsu ^d   Nakajima, Katsuyuki ^d  

^a Tokyo Medical and Dental University ^*  (Japan)

^b KAGAWA NUTRITION UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 3; APOLIPOPROTEIN A1; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CREATINE KINASE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD SAMPLING; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTER TRANSFER PROTEIN DEFICIENCY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CREATINE KINASE BLOOD LEVEL; FAT TOLERANCE TEST; FATTY LIVER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; OPHTHALMOLOGY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

ADULT; AGED; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; HEPARIN; HETEROZYGOTE; HUMANS; LIPIDS; MALE; PHENOTYPE; RISK; TRIGLYCERIDES;

EID: 73449094860     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.008249     Document Type: Article

References (35)

1. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153-8
2. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999;246:341-55
3. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993;90:2069-73
4. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb 2004;11:322-9
5. Ai M, Tanaka A, Ogita K, et al. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. J Am Coll Cardiol 2001;38:1628-32
6. Ai M, Tanaka A, Shoji K, et al. Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance. Atherosclerosis 2007;195:398-403
7. Ai M, Tanaka A, Ogita K, Shimokado K. Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes. Diabetes Care 2006;29:1180
8. Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990;323:1234-8
9. Inazu A, Jiang XC, Haraki T, et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994;94:1872-82
10. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23
11. Chiba H, Akita H, Tsuchihashi K, et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J Lipid Res 1997;38:1204-16
12. Guerin M, Egger P, Soudant C, et al. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state. J Lipid Res 2002;43:1652-60
13. Boekholdt SM, Kuivenhoven J-A, Wareham NJ, et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women. Circulation 2004;110:1418-23
14. Okamoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, Shinkai H. A cholesteryl ester transfer protein inhibitor attenuated atherosclerosis in rabbits. Nature 2000;406:203-7
15. Koishi R, Ando Y, Ono M, et al. Angptl3 regulate lipid metabolism in mice. Nat Genet 2002;30:151-7
16. Shimamura M, Matsuda M, Yasumo H, et al. Angiopoietin-like protein 3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 2007;27:366-72
17. Miida T, Seino U, Miyazaki O, et al. Probucol predominantly reduces HDL phospholipids together with elevated preb1-HDL without delayed conversion into a-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis 2008;200:329-35
18. Moon H, Nakajima K, Kamiyama K, Takanashi K, Sakurabayashi I, Nagamine T. Higher frequency of abnormal serum angiopoietinlike protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects. Clin Chim Acta 2008;398: 99-104
19. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002;43:805-14
20. Nishimura M, Ohkaru Y, Ishii H, et al. Development and evaluation of a direct sandwich-enzyme-linked immunosorbent assay for the quantification of human hepatic triglyceride lipase mass in human plasma. J Immunol Methods 2000;235:41-51
21. Imamura S, Kobayashi J, Sakasegawa S, et al. A novel method for measuring human hepatic lipase activity in postheparin plasma. J Lipid Res 2007;48:453-57
22. Imamura S, Kobayashi J, Nakajima K, et al. A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma. J Lipid Res 2008;49:1431-7
23. Ai M, Tanaka T, Ogita K, et al. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrin Metab 2000;85:3557-60
24. Inazu A, Nakajima K, Nakano T, et al. Decreased postprandial triglyceride response and unique remnant like particles (RLP) formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclerosis 2007;196:953-7
25. Okazaki M, Usui S, Tada N, et al. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin Chim Acta 2000;296:135-49
26. Sakai N, Uchida Y, Ohashi K, et al. Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res 2003;44:1256-62
27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20
28. Teh EM, Dolphin PJ, Breckenridge WC, Tan MH. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J Lipid Res 1998;39:442-56
29. Okamoto H, Miyai A, Sasase T, et al. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in plasma. Clin Chim Acta 2007;375:92-8
30. Ritsch A, Drexel H, Amann FW, Pfeifhofer C, Patch JR. Deficiency of cholesteryl ester protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma. Arterioscler Throm Vasc Biol 1997;17:3433-41
31. Usui S, Suzuki K, Yamanaka H, et al. Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques. Clin Chim Acta 2002;317:133-43
32. Ossewaarde ME, Dallinga-Thie GM, Bots ML, et al. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial. Eur J Clin Invest 2003;33:376-82
33. Nakajima K, Saito T, Tamura A, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 1993;223:53-71
34. Tall AR, Sammett D, Vita GM, Deckelbaum R, Olivecrona T. Lipoprotein lipase enhances the cholesteryl eater transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins. J Biol Chem 1984;259:9587-94
35. Marcoux C, Hopkins PN, Wang T, et al. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res 2000;41:1428-36